The European pharmaceutical industry is currently facing a significant productivity gap that has resulted in decreased market shares for innovative and profitable drug modalities. Moreover, around 30% of essential medicines have disappeared from the EU market over the last decade, with more at risk of vanishing. This decline is attributed to several factors, including insufficient digital factory infrastructure for producing sensitive drug modalities, rising cost pressures, labor shortages, and a persistent labor productivity gap.
This eBook is a practical guide tailored for European pharmaceutical manufacturers, outlining industry-specific digital transformation strategies. Real-world case studies demonstrate that EU manufacturers can scale production of biologics and ATMPs, multiply capacity to meet demand for sterile medicines, and reduce production costs by up to 50%, making them competitive with Asian producers in the generic medicine market.
What to Find in This eBook
Gain Insights into the European Pharma Industry and Future Expectations
Explore the current state of the European pharmaceutical industry, gain an understanding of the market dynamics, and learn about future expectations in a rapidly changing landscape.
Find Out the Reasons for the Productivity Gap in the European Pharma Industry
Learn about the six major causes of the productivity gap that European pharma manufacturers are facing today. Understand how issues like the lack of digital infrastructure, labor productivity, and underinvestment in workforce development are impacting the industry’s competitiveness.
Discover the DNA of Next-Generation Pharma Manufacturing
Explore the six digital transformation strategies that form the DNA of Pharma 4.0, from real-time monitoring and AI-driven scheduling to generative AI training solutions and predictive maintenance. Each strategy is geared towards building a more responsive, efficient, and innovative manufacturing environment.
Learn About the Expected Return on Digital Transformation for EU Pharma Manufacturers
Get an in-depth analysis of the expected ROI for Pharma 4.0 investments. From case studies, find out how pharma manufacturers have used digital transformation to boost Overall Equipment Effectiveness (OEE), improve schedule adherence, reduce costs, and enhance operational efficiency.
Find Best Practices to Maximize the Return of Your Pharma 4.0 Transformation
Discover best practices for implementing digital solutions successfully. Learn how to build a data-driven culture, prepare organizational structure, scale digital solutions effectively, and avoid future legacy costs. These practical tips will help EU pharma producers to maximize the impact of digital investments.
Who Should Read This eBook?
- Department Heads and Executives of European pharma manufacturers aiming to stay competitive.
- Digital Excellence teams of European pharma manufacturers
- Future department heads and executives of pharma manufacturers.
- Stakeholders of European pharma companies or global producers with operations in Europe.
- Consultants looking for insights into European pharma-specific challenges and strategies.
- NGOs collaborating with the European Commission to support the regional pharmaceutical sector.
- European Policy Makers seeking to understand how digital solutions can shape the future of the industry.
- Academics researching the European pharma industry or the broader productivity gap in Europe.
Download Ebook for Free and Transform Your Pharma Operations!
Equip your team with the knowledge and tools to close the productivity gap and drive innovation. Download the eBook today to embark on your journey towards the future of pharma factory.
Book a Demo with SCW.AI
Experience next-generation pharma manufacturing firsthand. See how SCW.AI’s Digital Factory Platform can drive your digital transformation journey. Book a demo with us today and explore the platform’s capabilities, from monitoring and compliance to AI-powered scheduling and streamlined task execution.
Frequently Asked Questions
How will this eBook help my business?
This eBook provides an in-depth look at the challenges European pharma companies face and offers actionable and proven strategies to improve productivity, reduce costs, and stay competitive.
Is this eBook relevant if I have already started digital transformation?
Absolutely. The eBook is valuable for manufacturers at any stage of digital maturity, with strategies that are relevant whether you are just beginning or enhancing your existing digital infrastructure.
How quickly can I expect to see results from implementing these strategies?
The timeline varies depending on the digital solutions deployed. Our clients typically see improvements within the first few months, with significant gains in OEE, schedule adherence, and cost efficiency within 12 months.
How is this eBook related to Mario Draghi's "The Future of European Competitiveness" report?
This eBook builds on the insights from Mario Draghi’s report, which highlights the productivity gap in European industries, including pharma. While Draghi’s report provides macro-level strategies that are not under control of European pharmaceutical manufacturers, this eBook focuses specifically on actionable digital transformation strategies to close the productivity gap. It tailors the recommendations to help companies address key challenges like low market share for new drug modalities, labor shortage, cost pressures etc., aligning with Draghi’s call for innovation and competitiveness in the EU.
If you have further questions on the productivity gap of the European pharma industry or digital transformation solutions and best practices you can contact us.